Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Daiichi Sankyo - Optimizing the treatment continuum with a molecular-based approach in HER2+ GI cancers

Our message worth sharing

Date

28 Jun 2024

Session

Daiichi Sankyo - Optimizing the treatment continuum with a molecular-based approach in HER2+ GI cancers

Presenters

Josep Tabernero

Authors

J. Tabernero1, S. Lonardi2, Z.A. Wainberg3

Author affiliations

  • 1 Vall d'Hebron University Hospital, Barcelona/ES
  • 2 IOV - Istituto Oncologico Veneto IRCCS, Padova/IT
  • 3 UCLA - David Geffen School of Medicine, Los Angeles/US

Resources

This content is available to ESMO members and event participants.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.